Literature DB >> 13663041

Growth inhibition of a human tumor cell strain by 5-fluoro-2-deoxyuridine: time parameters for subsequent reversal by thymidine.

M L EIDINOFF, M A RICH.   

Abstract

Entities:  

Keywords:  CYTOTOXIC DRUGS; NEOPLASMS/experimental; NUCLEOSIDES AND NUCLEOTIDES/effects

Mesh:

Substances:

Year:  1959        PMID: 13663041

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  THE CRYSTAL AND MOLECULAR STRUCTURE OF 5-FLURO-2'-DEOXY-BETA-URIDINE.

Authors:  D R HARRIS; W M MACINTYRE
Journal:  Biophys J       Date:  1964-05       Impact factor: 4.033

2.  Changes in the distribution of polymerase activity during DNA synthesis in mouse fibroblasts.

Authors:  J W LITTLEFIELD; A P McGOVERN; K B MARGESON
Journal:  Proc Natl Acad Sci U S A       Date:  1963-01-15       Impact factor: 11.205

3.  [Advances and results of cell culture methods].

Authors:  R SCHINDLER
Journal:  Experientia       Date:  1961-03-15

4.  DNA Multiplication as a Requirement for Expression of Floral Stimulus in Pharbitis nil.

Authors:  J A Zeevaart
Journal:  Plant Physiol       Date:  1962-05       Impact factor: 8.340

5.  [Studies on synchronisation in vivo: temporary inhibition of DNA synthesis in normal and malignant mammalian cell systems with hydroxyurea].

Authors:  M F Rajewsky; D F Hülser; E Fabricius
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

6.  Replication of DNA in larval salivary glands of Drosophila after in vivo synchronization.

Authors:  P M Achary; K Majumdar; A Duttagupta; A S Mukherjee
Journal:  Chromosoma       Date:  1981       Impact factor: 4.316

7.  In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.

Authors:  R S Camplejohn; B Schultze; W Maurer
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

Review 8.  DNA methyltransferases: a novel target for prevention and therapy.

Authors:  Dharmalingam Subramaniam; Ravi Thombre; Animesh Dhar; Shrikant Anant
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.